XML 66 R55.htm IDEA: XBRL DOCUMENT v3.23.2
Net Loss Per Share - Antidilutive Securities Excluded from Computation of Earnings Per Share (Details) - shares
3 Months Ended 6 Months Ended
Aug. 10, 2023
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]          
Total   14,472,795 11,068,175 14,472,795 11,068,175
Options          
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]          
Total   12,056,731 8,779,368 12,056,731 8,779,368
Options | Subsequent Event | GeneFab          
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]          
Total 19,633,444        
Unvested early exercised options          
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]          
Total   80,180 288,807 80,180 288,807
Restricted Stock Units (RSUs)          
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]          
Total   335,884 0 335,884 0
Contingent earnout common stock          
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]          
Total   2,000,000 2,000,000 2,000,000 2,000,000